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A sensitive D-amino acid oxidase (DAAO)/peroxidase (POD) bienzyme biosensor 
is constructed, in which pentacyanoferrate-bound poly(1-vinylimidazole) polymer 
(PVI[Fe(CN)5]) is selected as a mediator. Reductive current of PVI[Fe(CN)5] related to 
the H2O2 concentration generated in the DAAO reaction was measured at −0.1 V vs. 
Ag|AgCl with DAAO/POD/PVI[Fe(CN)5]-modified electrode. The result revealed that 
PVI[Fe(CN)5] is suitable as a mediator for this bienzyme system due to its appropriate 
formal potential and its extremely low reactivity against DAAO. The stability of DAAO 
was improved by adding free flavin adenine dinucleotide and the electrode composition 
was optimized for the detection of D-alanine. Nafion and ascorbate oxidase-immobilized 
films worked successfully to prevent severe interference from uric acid and ascorbic 
acid. The low detection limits of D-alanine (2 μM) and D-serine (2 μM) imply its 
possibility for the determination of extremely low concentration of D-amino acids in 
physiological fluids. The proposed bienzyme biosensor is proved to be capable of 
detecting D-amino acids in urine.   
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The role of D-amino acids (DAAs) has become of great importance in life science, 
since several DAAs are found to have physiological functions in mammals. With regard 
to the central nervous system in brain, D-serine acts as a co-agonist of N-methyl- 
D-asparate receptor, which is associated with learning and memory (Bains and Oliet, 
2007), and D-alanine in the anterior pituitary gland, pancreas, and plasma might have a 
physiological function to the insulin regulation (Hamase et al., 2009). The concentration 
of DAAs also shows a strong correlation to some diseases. For example, the ratio of 
D-serine to the total (D-+ L-) serine concentration in the serum of Alzheimer’s disease 
patients was reported to be lower than that of normal subjects (Hashimoto et al., 2004). 
As the dynamic monitoring of the DAAs concentration is of acute interest, a rapid, 
simple and highly sensitive method for the DAA detection is essential for further study. 
Separation-based analytical methods such as high performance liquid chromatography 
(HPLC) and capillary electrophoresis are conventionally used for DAA determination 
with high sensitivity (Hashimoto et al., 1992; Quan et al., 2005). D-Amino acid oxidase 
(DAAO) oxidizes DAAs to the corresponding imino acids, which have been further 
utilized to react with o-phenylenediamine and 2-mercaptoethanol to form the 
corresponding fluorescent quinoxalinol derivatives. The fluorescent derivatives can be 
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separated by HPLC and this method eliminates the interference from extremely high 
concentrations of L-amino acids (Kato et al., 2010; Oguri et al., 2005). Considering the 
convenience for in vivo detections and the undesirability of cumbersome instruments, 
enzyme-based amperometric biosensors are favored for DAA detection. DAAO is a 
flavoenzyme and is widely used in enzymatic biosensors for DAA determination, either 
based on the direct detection of generated H2O2 (Pernot et al., 2008; Sacchi et al., 1998; 
Zain et al., 2010) or the detection of artificial mediators used as electron acceptors of 
the substrate-reduced DAAO (Eqs. 1-3) (Arai et al., 1998; Murthy and Sharma, 1999). 
 AAs  AA   A   imi   a ids  AA   A                             (1) 
 AA   A          r media  rs  AA   A          r red  ed media  rs    (2) 
       r red  ed media  rs 
            s  A  A  l
                     r   idized media  rs    
   e-   (3) 
However, the oxidation of both H2O2 and mediators requires high operation potential, 
which always accompanies the co-oxidation of other electroactive metabolites in 
physiological fluids. In addition, the exclusion of O2 in the case of mediated biosensors 
seems to be impractical for in vivo analysis.  
 On the other hand, peroxidase (POD) in combination with H2O2–producing 
oxidases including DAAO has been studied intensively in recent years for the substrate 
detection in the way of direct or mediated electron transfer (Dominguez et al., 2001; 
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Kacaniklic et al., 1994). As shown in Eq. 4, in mediated bienzyme biosensors, H2O2 is 
reduced by POD and the oxidized mediators with a suitable formal potential can be 
reduced on an electrode at low operating potentials around 0 V vs. Ag|AgCl.  
     media  rs
   
         idized media  rs              (4) 
Since the low potential operation decreases the background current and noise levels, and 
eliminates the undesirable oxidation of electroactive interferents, bienzyme biosensors 
show high sensitivity and stability. However, such mediated bienzyme sensors may have 
one problem to be overcome; the oxidized mediators (in Eq. 3) may also act as electron 
acceptors of H2O2-producing oxidases based on the dehydrogenase activity of the 
oxidase (Matsumoto et al., 2002; Ohara et al., 1993b). The reaction diminishes the 
cathodic current to interfere the determination of the substrate concentration. In 
consideration of 1) the possibility of cross reaction of mediators with POD and oxidases, 
2) the interference effect of O2 red   i   ar   d −      (vs. Ag|AgCl), and 3) the 
occurrence of oxidation of interferents at positive potentials, it becomes an important 
issue for mediated bienzyme biosensors to select an appropriate mediator with high 
selectivity for POD alone and a suitable operating potential in the narrow range from 
−0.2 to 0 V. 
Here, we focus our attention on pentacyanoferrate-bound poly(1-vinylimidazole) 
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polymer (PVI[Fe(CN)5]), which has been synthesized in our group (Ishibashi et al., 
2008), as an mediator for the DAAO/POD bienzyme biosensor considering its suitable 
formal potential and the poor mediating capability of ferricyanide for other 
flavoenzymes such as glucose oxidase (Kulys and Cenas, 1983; Nieh et al., 2012). 
PVI[Fe(CN)5] is one kind of electro-conducting hydrogels which can covalently bind 
enzymes through poly(ethylene glycol) diglycidyl ether (PEGDGE) and shuttle 
electrons between enzymes and electrode (Ohara et al., 1993a). In this work, the 
interactions of PVI[Fe(CN)5] with POD and DAAO will be studied, and the electrode 





 , ’-Azobisisobutyronitrile (AIBN), sodium pentacyanonitrosylferrate(III) dihydrate 
(Na2[Fe(CN)5(NO)]∙2H2O), D-serine, ascorbic acid (AA), uric acid (UA), 
glutaraldehyde (GA, 20%), and flavin adenine dinucleotide (FAD) disodium salt were 
obtained from Wako Chem. Co. (Osaka, Japan). 1-Vinylimidazole, DAAO from porcine 
kidney (8.2 U mg
−1
), PEGDGE, D-alanine, and Nafion (5 wt% in mixture of lower 
aliphatic alcohols and water, contains 45% water) were from Sigma-Aldrich (USA). 
Peroxidase from horseradish (POD, 257 U mg
−1
) and ascorbate oxidase from cucumis 
sp. (AO, 333 U mg
−1
) were purchased from Toyobo Co. (Osaka, Japan). UA solution 
was prepared with 10 mM NaOH, FAD was dissolved in distilled water, and the 
enzymes, substrates, AA and PEGDGE solutions were prepared with 30 mM potassium 
phosphate buffer (pH 7.0). Other chemicals were of analytical grade and used as 
received. The urine sample was donated from a healthy volunteer. 
2.2 Synthesis of PVI[Fe(CN)5] 
Poly(1-vinylimidazole) (PVI) was synthesized as reported (Ohara et al., 1993a). In 
brief, a mixture of 1-vinylimidazole and 0.5 g of AIBN (6 mL) was heated under stirring 
at 70 °C for 2 h in Ar. The yellow precipitate was then dissolved in methanol, followed 
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by adding dropwise to acetone under strong stirring to get white soft precipitate. PVI 
powder was obtained after filtering and drying.  
PVI[Fe(CN)5] was then synthesized according to the literature (Ishibashi et al., 
2008). Briefly, 100 mg of Na2[Fe(CN)5(NO)]∙2H2O and 94 mg of PVI were dissolved in 
25 mL of 0.6 M NaOH and refluxed at 65 °C for 24 h. The solution was then dialyzed 
against distilled water for 24 h to remove unreacted compounds. After filtration to 
remove red precipitate, the suspension was vacuum freeze-dried at −40 °C for 24 h to 
get PVI[Fe(CN)5] powder. The ratio of the imidazole unit in PVI to the Fe(CN)5 
complex was 4.3 as measured by elemental analysis. The stock solution of PVI[Fe(CN)5] 
was prepared in distilled water.  
2.3 Coimmobilization of POD, DAAO and PVI[Fe(CN)5] 
A solution containing PVI[Fe(CN)5], PEGDGE, POD and DAAO was cast onto the 
surface of a glassy carbon electrode (3 mm diameter, BAS) and well mixed with a 
syringe needle. The electrode was dried at 4 °C for 24 h. Before measurements, the 
proposed electrode was immersed into a 30 mM potassium phosphate buffer (pH 7.0) 
for 20 min.  
2.4 Fabrication of interference-free bienzyme electrode  
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To improve the stability of DAAO, 1 μL of 400 μM FAD solution (4×10−10 mol, ca. 
0.3 μg) was cast onto the proposed electrode fabricated in section 2.3 (see section 3.2 
for details). For interference tests, 3 μL of Nafion solution diluted by distilled water was 
then added onto the electrode after air-drying. Unbounded polymer and enzymes were 
removed by dipping the electrode into distilled water and 3μL of diluted Nafion solution 
was cast onto the electrode again after air-drying. Finally, AO was crosslinked with GA 
on the electrode at 4 °C for 2 h. 
2.5 Electrochemical measurements 
Electrochemical experiments were carried out in a potassium phosphate buffer (pH 
8.0, 30 mM) under stirring at 37 °C with an electrochemical analyzer (611B or 1000, 
CH Instrument, USA). The reference and counter electrodes were an Ag|AgCl|sat. KCl 




Oxygen depletion due to the DAAO reaction was measured at 37 °C and −0.6 V 
with a Clark-type oxygen electrode (Optoscience, Japan). The pH 8.0, 30 mM 
potassium phosphate buffer solution containing 3 μg mL−1 DAAO and 4 mM D-alanine 




3. Results and discussion 
3.1 Reactivities of PVI[Fe(CN)5] against DAAO and POD 
Such oxidase/POD bienzyme systems may suffer from interference due to the 
dehydrogenase activity of oxidase. As shown in Scheme 1(hollow arrows), the oxidized 
form of some mediators may accept electrons from DAAO, which interferes the 
substrate detection. In this sensing system, PVI[Fe(CN)5] was selected as a mediator. 
Figure 1A shows that PVI[Fe(CN)5] has extremely low reactivity against DAAO, while 
in the POD reaction the catalytic current is clearly observed with PVI[Fe(CN)5] (Fig. 
1B). The result indicates the poor interaction between DAAO and PVI[Fe(CN)5]. The 
quite different reactivities of PVI[Fe(CN)5] against DAAO and POD are interpreted as 
follows: The redox center (FAD) of DAAO locates in hydrophobic surroundings and is 
deeply buried in the interior to induce the steric hindrance (Mizutani et al., 1996); 
PVI[Fe(CN)5] with negatively charged ligands would be difficult to enter into the 
FAD-catalytic center. Therefore, no obvious mediating effect of PVI[Fe(CN)5] was 
observed for the DAAO reaction. On the other hand, the redox center (protoheme group) 
of POD locates near the enzyme exterior with widely open entrance; furthermore, the 
electrostatic potential around the redox center is positively charged (Carlsson et al., 
2005), which makes it easier for PVI[Fe(CN)5] to shuttle electrons between POD and 
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electrode. Thus, we can conclude that PVI[Fe(CN)5] is very suitable as the mediator for 
the DAAO/POD bienzyme biosensor with high specificity.  
3.2 Stability of DAAO/POD/ PVI[Fe(CN)5]-modified electrode 
DAAO/POD/PVI[Fe(CN)5]-modified electrode has been successfully constructed 
herein for the DAA detection. However, as shown in Fig. 2A, the current response of 
D-alanine decreased with successive operations (open square); the current value in the 
third detection is only two third of that in the first detection. We considered that the poor 
repeatability of the detection is mainly due to the non-covalent binding property of FAD 
with DAAO (Arai et al., 1998). Since the binding between FAD and apo-DAAO is 
weak, FAD gradually releases from holo-DAAO to the bulk solution to lead the 
decrease in the DAAO activity. Considering keeping the activity of DAAO, sufficient 
amount of FAD was added into the experimental solutions to avoid the leakage of FAD 
from holo-DAAO. The effect of the FAD addition was checked by detecting the oxygen 
depletion in the DAAO reaction measured with the Clark-type oxygen electrode (Fig. 
2B). At a low concentration of DAAO without FAD addition (dash line), the activity of 
DAAO gradually decreased since FAD easily released from DAAO to the bulk solution. 
On the other hand, the oxygen depletion rate of the DAAO reaction increased and 
DAAO became more stable in the presence of 40 μM FAD (solid line). The high oxygen 
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depletion rate in the FAD-containing solution indicates that the addition of FAD keeps 
the DAAO activity. Good repeatability of the proposed biosensing system was then 
proven by addition of FAD in the test solution, as evidenced in Fig. 2A (closed 
rhombus); no drastic decrease in the current response was observed in the successive 
experiments. Therefore, the experimental solution containing 40 μM FAD was selected 
in the following experiments for other optimization.  
Considering the fact that the biosensor sensitivity is related to the deposited 
polymer thickness, the composition of POD and DAAO, and the total enzyme capacity, 
the dependence of the current response on the amount of PVI[Fe(CN)5], the ratio of 
POD to DAAO, and the weight ratio of the enzymes to the total weight were examined. 
The results are shown in Fig. S1. The optimized values were determined as follows: 20 
μg of PVI[Fe(CN)5], 0.1 (the ratio of POD to DAAO), and 0.6 (the weight ratio of the 
enzymes to the total weight). The final composition of proposed electrode contains 20 
μg of PVI[Fe(CN)5], 10 μg of PEGDGE ,1.07 U of POD and 0.33 U of DAAO. 
3.3 Interference effect 
The DAA bienzyme biosensor at low operating potential minimizes the undesirable 
oxidation of electroactive reducing interferents in physiological samples. However, 
some interferents may react as electron donors for POD to affect the detection. 
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     idized i  er ere  s                                 (5) 
This reaction interferes with the electron transfer between reduced PVI[Fe(CN)5] 
and POD and causes the underestimation of the DAA concentration. To eliminate the 
interference effect, negatively charged Nafion was used as a protecting film on the top 
of the bienzyme electrode to exclude anionic interferents such as AA and UA based on 
electrostatic repulsion. In addition, 0.3 μg of FAD was cast between the bienzyme layer 
and the Nafion film in place of the FAD addition in the experimental bulk solution. 
Furthermore, regarding the low oxidation potential of AA, 15 μ  of AO was 
immobilized with GA on the top of the Nafion film to minimize the interference effect 
of AA. In separated experiments, it has been proved that PVI[Fe(CN)5] works neither as 
a substrate (reduced form) for AO nor as an electron acceptor of AO in the catalytic 
oxidation of AA (data not shown). Since PVI[Fe(CN)5] shows low reactivity against AO, 
AO utilization does not affect the DAA detection. The interference effect on the 
amperometric response with different concentrations of Nafion is shown in Table 1; the 
current response of 10 μM D-alanine decreased with an increase of the Nafion amount 
because of the thick film which decreases the mass transfer of the substrate. Comparing 
the response of D-alanine with that in the AA-containing solution, the relative response 
increased with an increase of the Nafion amount; thick Nafion film shows a better 
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protecting effect. The relative responses over than 100% with very thick Nafion films 
may be due to the partial desorption of the Nafion film in succeeding measurements for 
the DAA+AA mixture, which increases the penetration of D-alanine. Taking the current 
response and the protecting effect into account, 0.8% Nafion was selected for the 
biosensor fabrication, and no significant interference was observed in the 10 μM 
D-alanine solution containing 500 μM UA and 100 μM AA (data not shown). The 
physiologically normal concentration of UA in urine is about 30 times higher than 
DAAs, and the normal concentration of AA is in the same level with DAAs (Bruckner 
and Schieber, 2001; Westerman et al., 2000; Zuo et al., 2011). Therefore, this bienzyme 
biosensor protected by Nafion and AO seems to satisfy the DAA determination in urine. 
3.4 Sensors for DAAs 
The proposed bienzyme biosensor protected by Nafion and AO has successfully 
worked for the DAA determination in the presence of high concentrations of interferents. 
However, in the preliminary test of urine sample, the sensitivity decreased gradually 
with successive measurements (data not shown). Some molecules in the urine sample 
may nonspecifically adsorb on the AO layer of the electrode, which fouled the electrode 
to affect the sensitivity. To eliminate the nonspecific adsorption, 6 μL of 0.8% Nafion 
was cast on the top of the AO layer for protection. The illustrated structure of the DAA 
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biosensor is shown in Scheme 2. Most of the interferents are inhibited from entering 
into the sensing part by the outer Nafion film, and the residual UA and AA are blocked 
by the inner Nafion film and oxidized by AO, respectively. Thus, DAAs can 
successfully be detected without interference effect. 
Amperometric responses of two major DAAs in human body, D-serine and 
D-alanine, are presented in Fig. S2, in which the current was measured with the 
 p imized bi se si   ele  r de a  −    . The detection limits of D-serine and D-alanine 
are both 2 μM (S/N > 3); the linear ranges are from 10 to 350 μM and 5 to 150 μM, and 
the slopes are 5.4 and 9.7 nA μM−1, respectively. It shows that the biosensor has very 
low detection limit and high sensitivity, which is suitable for the detection of extremely 
low concentrations of DAAs in physiological samples. The different reactivities of 
different DAAs indicate that it is difficult for DAAO-based biosensors to determine the 
total concentration of DAA. Nevertheless, it is still benefit to easily determine the total 
performance of DAAs with selecting one of DAAs, such as D-alanine, as a standard.  
The standard-addition method was then used for a urine sample test. D-Alanine was 
successively injected into the urine solution which was 100 times diluted with 30 mM 
potassium phosphate buffer (pH 8.0) and the slope is similar to that measured in the 
standard D-alanine solution (Fig. S3). The concentration of DAAs in the urine was 
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evaluated to be 147±16 μM, when D-alanine was selected as a standard. The sensitivity 
of biosensor is not affected by the interferents in urine. The DAAO/POD bienzyme 





DAAO/POD bienzyme biosensor has successfully been constructed for the DAA 
determination. PVI[Fe(CN)5] is suitable as a mediator and for enzyme immobilization 
based on its appropriate formal potential and poor reactivity with DAAO. The 
interference effect has been eliminated by the Nafion films and AO, and the biosensor 
has low detection limit and high sensitivity, which indicates its applicability for clinical 
diagnosis. Since the main species of DAAs in human brain is D-serine, the proposed 
biosensor seems to have a potential for D-serine determination in brain without the 
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Scheme 1  
Possible reactions in mediated DAAO/POD bienzyme sensor.  
 
Figure 1  
Cyclic voltammograms of (A) DAAO/PVI[Fe(CN)5]-modified electrode in an 
Ar-saturated solution and (B) DAAO/POD/PVI[Fe(CN)5]-modified electrode in an 
Air-saturated solution. The dash line is the detection in a buffer solution and the solid 
line is the detection in 4 mM D-alanine (pH 8.0). Electrode composition, DAAO: 0.33 U, 




Figure 2  
(A) Dependence of the current response at –0.1 V on the successive measurements in 
the solution containing 40 μM FAD and 5 μM D-alanine (closed rhombus) or 5 μM 
D-alanine only (open square). Electrode composition, DAAO: 0.25 U, POD: 2.67 U, 
PEGDGE: 10 μg, PVI[Fe(CN)5]: 30 μg. (B) Time dependence of the dissolved oxygen 
concentration during the DAAO reaction in the solution containing 40 μM FAD and 4 




Scheme 2  
The composition and the reaction sequence of the proposed DAAO/POD bienzyme 
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Figure S1 Dependence of the amperometric response on the (A) amount of 
PVI[Fe(CN)5], (B) the weight ratio of POD to DAAO and (C) the weight ratio of the 
enzymes to the total weight in the detection of 5 μM D-alanine at –0.1 V. All 









































Figure S2 (A) Dependence of the amperometric response on the concentration of 
D-alanine (open circle) and D-serine (closed square) at –0.1V. Current response (nA) = 
9.7 (nA μM−1)×[D-alanine] (μM)−40.7 (nA), R2=0.999, and Current response (nA) = 
5.4 (nA μM−1)×[D-serine] (μM)−62.3 (nA), R2=0.999, respectively. The inset shows the 
current response in the wide range of the DAA concentration. (B) One part of typical 

















































Figure S3 Standard addition measurements of a urine sample, which was 100 times 
diluted with 30 mM potassium phosphate buffer (pH 8.0). Current response (nA) = 
5.8±0.1 (nA μM−1)×[D-alanine] (μM)+8.8±0.7 (nA), R2=0.998. The average values and 
the error bars are obtained from triplicate measurements. The slope of 5.7 nA μM−1 
means the sensitivity of the bienzyme biosensor for the D-alanine detection in the 
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